ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    Intact Lymphatics Are Essential for Costimulation Blockade-Induced Lung Allograft Survival

    L. Wang1, H. Reed2, R. Han1, M. Kahn2, W. W. Hancock1

    1Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA

    *Purpose: Blocking lymphangiogenesis is thought to diminish immune responses to donor tissues. However, lung transplantation (Tx), which involves airway and vascular but not lymphatic anastomoses,…
  • 2019 American Transplant Congress

    Depletional Induction Therapy in Non-Human Primates – Preclinical Modeling of Polyclonal Depletion with Rhesus-Specific ATG

    R. Schmitz1, M. S. Mulvihill1, P. M. Schroder1, Z. Fitch1, F. Leopardi1, D. Magnani2, J. Kwun1, S. J. Knechtle1, A. D. Kirk1

    1Surgery, Duke University Medical Center, Durham, NC, 2University of Massachusetts Medical School, Boston, MA

    *Purpose: Antithymocyte globulins (ATG) have been used in transplantation since the late 1960s to prevent and treat acute allograft rejection. Over the past decade, induction…
  • 2019 American Transplant Congress

    Effects of Standard Drug Immunosuppression on Peripheral Transitional B Cells and Gene Expression in Non-Human Primates

    A. Bean1, J. Paster1, K. Pruner1, J. O1, W. Sommer2, K. Robinson3, I. Hanekamp1, G. Benichou1, J. Madsen1

    1Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, 2Klinik fur Herz Thorax Transplantation, Medizinische Hochschule Hannover, Hannover, Germany, 3Beth Israel Deaconess Medical Center, Boston, MA

    *Purpose: Operationally tolerant renal transplant recipients exhibit an increased number of transitional B cells and an upregulation of selected B-cell associated genes in the periphery…
  • 2019 American Transplant Congress

    Increasing Expression of B-cell Maturation Antigen during the Development of Recall Antibody Responses: A Prospective Pharmaceutical Target for B-cell Suppression?

    G. Wu, I. Kim, N. Chai, A. Klein, S. Jordan

    Cedars-Sinai Med Ctr, Los Angeles, CA

    *Purpose: Our previous study found that B cell maturation antigen (BCMA) is increasingly expressed by B/plasma cells during the development of de novo alloantibody responses.…
  • 2019 American Transplant Congress

    Deceased Donor Vascularized Abdominal Wall Allograft Procurement – Lessons Learned from Early Experiences

    J. A. Shah, D. L. Sudan, D. Erdmann, K. V. Ravindra

    Abdominal Transplant Surgery, Duke University Medical Center, Durham, NC

    *Purpose: Vascularized abdominal wall allografts (AWA), which protect solid organs in patients with loss of abdominal domain or extensive abdominal wall damage, remain an essential…
  • 2019 American Transplant Congress

    Differential Regulation of Phosphokinases by Anti-HLA Class I and 11 Antibodies

    A. Babu1, B. Tran2, M. Hamdorf2, V. Jucaud2, S. Daga3, D. Mitchell4, M. Everly2

    1Henry Ford Hospitals, Detroit, MI, 2Terasaki Research Institute, Los Angeles, CA, 3University of Warwick, Coventry, United Kingdom, 4Medical Sciences, University of Warwick, Coventry, United Kingdom

    *Purpose: Anti-HLA antibodies, both pre-formed and de novo are associated with worse graft survival. Glomerular endothelial cells are the targets for antibody mediated rejection. We…
  • 2019 American Transplant Congress

    Perfluorocarbon (PFC) Solutions for Organ Preservation

    N. Battula, T. Parsons, J. Zhu, C. Giordano, A. Esnakula, B. Spiess, M. Johnson, A. Zarrinpar, K. Andreoni

    University of Florida, Gainesville, FL

    *Purpose: The current status of organ transplantation demands consideration of extended criteria (ECD) brain dead donors (DBD) as well as donation after circulatory death (DCD)…
  • 2019 American Transplant Congress

    Graft TIM4 Deficiency Protects Liver from Ischemia Reperfusion Injury: From Mouse to Human

    S. Kageyama1, K. Kadono1, H. Hirao1, K. Nakamura1, T. Ito2, K. J. Dery1, D. Oncel1, B. Ke1, F. M. Kaldas2, R. W. Busuttil2, J. W. Kupiec-Weglinski1

    1Surgery, Dumont-UCLA Transplant Center, Los Angeles, CA, 2Surgery, Ronald Reagan UCLA Medical Center, Los Angeles, CA

    *Purpose: Liver ischemia-reperfusion injury (IRI) is a major risk factor for early graft dysfunction and rejection in orthotopic liver transplantation (OLT). We and others have…
  • 2019 American Transplant Congress

    Insulin Treatment in Pancreas Donors on the Intensive Care is a Marker of Beta Cell Death as Evidenced by microRNA Data

    I. Shapey, A. Summers, J. O'Sullivan, P. Yiannoullou, N. Hanley, T. Augustine, M. Rutter, D. van Dellen

    University of Manchester, Manchester, United Kingdom

    *Purpose: We showed in prior studies that donor insulin use on intensive care predicts early beta cell dysfunction in islet and solid pancreas transplantation. We…
  • 2019 American Transplant Congress

    Use Of Perirenal Adipose Tissue As A Source Of Donor Cells Allowing Evaluation Of Endothelial Inflammation And Quality Of Expanded Criteria Kidneys

    R. Boissier1, L. Lyonnet2, P. Francois3, M. Meunier4, B. Gondran-Tellier5, T. Legris6, J. Magalon5, C. Picard7, F. Dignat George5, E. Lechevallier8, G. Karsenty8, F. Sabatier9, P. Paul1

    1INSERM 1263, Centre de recherche en cardiovasculaire et nutrition, INSERM, Aix Marseille Univ, Assistance Publique Hopitaux Marseille, Marseille, France, 2Vascular Biology and Hematology department, Assistance publique Hopitaux Marseille (AP-HM), Marseille, France, 3INSERM 1263, Centre de recherche en cardiovasculaire et nutrition, INSERM, Aix Marseille Univ., Marseille, France, 4Nephrology Dialysis and Renal Transplantation Center, AP-HM, Marseille, France, 5INSERM 1263, C2VN, INSERM, Aix Marseille Univ., Marseille, France, 6Nephrology Dialysis and Renal Transplantation Center, AP-HM, Marseille, France, 7Etablissement Français du Sang, Alpes Méditerranée, Marseille, France, 8Urology and Transplantation Unit , AP-HM, Marseille, France, 9INSERM 1263, Centre de recherche en cardiovasculaire et nutrition, INSERM, Aix Marseille Univ, Marseille, France

    *Purpose: Use of expanded-criteria donor (ECD) kidneys is a perspective to overcome organ shortage. Age and donor-related co-morbidy factors are known to affect graft function…
  • « Previous Page
  • 1
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences